[The parenteral administration of terridecase in the treatment of suppurative-inflammatory diseases of the hand].
Patients with purulent inflammatory diseases were treated by parenteral administration of terrydecaza (polyglucin-immobilised terrylythin). It was noted that injections of terrydecaza facilitated the penetration of antibiotics to the purulent focus. The terms of cleansing the purulent wounds and transition of the inflammatory process to the second stage were 2-3 days shorter. The microcirculation was improved by the daily thermographic monitoring method. The increased penetration through the biological membranes was confirmed by higher concentration of middle weight molecules in plasma of the venous blood flowing off from the purulent focus.
Konychev
A V
AV
Kaiukov
A V
AV
D000681:Amylases / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004800:Enzymes, Immobilized / Q000008:administration & dosage*; D006225:Hand; D006801:Humans; D007273:Injections, Intramuscular; D010304:Paronychia / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D010447:Peptide Hydrolases / Q000008:administration & dosage*; D013817:Thermography; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D004800:Enzymes, Immobilized; C009402:amylase, phosphates, proteases drug combinations; D000681:Amylases; D010447:Peptide Hydrolases